BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 9417570)

  • 81. Oral contraception and the risk of thromboembolism: what does it mean to clinicians and their patients?
    Drife J
    Drug Saf; 2002; 25(13):893-902. PubMed ID: 12381211
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Current developments in hormonal contraception].
    Hamerlynck JV
    Ned Tijdschr Geneeskd; 1982 Oct; 126(44):2018-21. PubMed ID: 7177211
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Increased risk from third-generation progestogens: fuzzy logic or fuzzy science?
    Corson SL
    J Reprod Med; 1996 Sep; 41(9):711-2. PubMed ID: 8887199
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Venous thromboembolic disease and oral contraceptives].
    Overgaard K; Hauch O; Lidegaard O
    Ugeskr Laeger; 1986 Sep; 148(37):2348-50. PubMed ID: 3775922
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Warnings on venous thromboembolism risks may have been premature. New data may lead to change in use of third-generation OCs.
    Contracept Technol Update; 1997 Dec; 18(12):145-8. PubMed ID: 12348219
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of steroidal contraceptives on gallbladder: a review.
    Kenya PR
    East Afr Med J; 1990 Sep; 67(9):661-6. PubMed ID: 2253576
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors.
    Pabinger I; Schneider B
    Thromb Haemost; 1994 May; 71(5):548-52. PubMed ID: 8091378
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Hormonal contraceptives and venous thromboembolism: an epidemiological update.
    Plu-Bureau G; Maitrot-Mantelet L; Hugon-Rodin J; Canonico M
    Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):25-34. PubMed ID: 23384743
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Thrombotic risks of oral contraceptives.
    Rott H
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Low-dose oral contraception and thrombosis.
    Gordon EM
    J Lab Clin Med; 1987 Jun; 109(6):621-2. PubMed ID: 3585137
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Sensitivity to activated protein C; influence of oral contraceptives and sex.
    Henkens CM; Bom VJ; Seinen AJ; van der Meer J
    Thromb Haemost; 1995 Mar; 73(3):402-4. PubMed ID: 7667823
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Oral contraception and cerebral thromboembolism.
    Lidegaard O
    Acta Obstet Gynecol Scand Suppl; 1997; 164():66-8. PubMed ID: 9225642
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O; Spinar J; Musil V; Pozdísek Z
    Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The estrogen component of OCs: cardiovascular benefits and risks.
    Burkman RT
    Int J Fertil Womens Med; 1997; Suppl 1():145-57. PubMed ID: 9168374
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Real and seeming side-effects of oral contraceptives with an emphasis on medical and haematological problems. Review of literature (author's transl)].
    Bucher U; Kägi M; Beck EA
    Schweiz Rundsch Med Prax; 1976 May; 65(19):570-80. PubMed ID: 790374
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Oral contraceptives and thrombosis. From risk estimates to health impact.
    Lidegaard O; Bygdeman M; Milsom I; Nesheim BI; Skjeldestad FE; Toivonen J
    Acta Obstet Gynecol Scand; 1999 Feb; 78(2):142-9. PubMed ID: 10023878
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Antithrombin III deficiency, deep venous thrombosis, and oral contraceptive use.
    Werner MJ
    J Adolesc Health; 1995 Sep; 17(3):189-92. PubMed ID: 8519788
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Ictus, pregnancy and contraception].
    Pareja A; Láinez JM
    Rev Neurol; 1995; 23 Suppl 1():S87-90. PubMed ID: 7497275
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Survey of general practitioner instructions to oral contraceptive users.
    Kovacs GT; Murtagh J
    Aust Fam Physician; 1994 May; 23(5):915-8. PubMed ID: 8037631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.